NHS cancer patients wait 14 years for new drugs – 18 months longer than in 2008


Cancer drug development has slowed by 18 months due to EU red tape leaving patients waiting 14 years for new treatment, a damning new report has warned.

The Institute of Cancer Research (ICR) found that excessive inspections, and needless safety reporting when testing already licensed drugs in different cancer types, has increased admin and made it far more expensive to run clinical trials.

It means that NHS patients are now waiting 14.1 years rather than 12.7 years in 2008, for drugs to be available, even though Nice has speeded up approval in that period by seven months.

The average time taken between the start of phase I clinical trials of a drug and authorisation by the European Medical Agency…

You might also like More from author

Leave A Reply

Your email address will not be published.